By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actavis 

Morris Corporate Center III
400 Interpace Parkway
Parippany  New Jersey  07054  U.S.A.
Phone: 1-862-261-7000 Fax: n/a


SEARCH JOBS

Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland.

Actavis is the world’s third-largest generics prescription drug manufacturer, with more than 750 products marketed globally through operations in more than 60 countries. Actavis’ global branded pharmaceutical business develops and markets products principally in Urology and Women’s Health, and is committed to developing and marketing biosimilars products in Women’s Health, Oncology and other therapeutic categories. In addition, Actavis is the fourth-largest U.S. generic pharmaceutical product distributor through its Anda, Inc. business, and also develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.

"Twice As" Video

"Our Winning Way" Video


Key Statistics


Email: actavis@actavis.com
Ownership: Public

Web Site: Actavis
Employees:
Symbol: ACT
 



Industry
Pharmaceutical






Company News
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014 5:34:30 AM
Noven Pharmaceuticals Inc. Files Patent Infringement Lawsuit Against Actavis (ACT) 10/17/2014 10:44:35 AM
Actavis (ACT) Confirms Generic Quillivant XR® Patent Challenge 10/16/2014 7:58:01 AM
Fidelity Ups Its Stake In Allergan Inc. (AGN) As Actavis (ACT) Bid Rumors Fly; Potential $60 Billion Deal 10/10/2014 6:48:58 AM
Ironwood Pharmaceuticals (IRWD) And Actavis (ACT) To Present Linaclotide Data At The American College of Gastroenterology 2014 Annual Scientific Meeting 10/9/2014 10:48:04 AM
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014 6:19:48 AM
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014 5:51:58 AM
Supernus Pharmaceuticals (SUPN) Sues Actavis (ACT) For Infringement Of Trokendi XR® Patents 10/2/2014 8:08:24 AM
If Allergan Inc. (AGN) Survives Valeant (VRX), AbbVie (ABBV), Shire or Actavis (ACT)/Forest May Be Suitors 9/30/2014 3:50:01 PM
Actavis (ACT) To Host Third Quarter 2014 Earnings Conference Call And Webcast 9/30/2014 8:46:26 AM
12345678910...
//-->